Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1399954
                    [Title] => Selenium slows Graves’ orbitopathy progression
                    [Summary] => 
Oral selenium significantly improves patients’ quality of life and slows the progression of mild Graves’ orbitopathy, according to the findings of a year-long randomized controlled trial.

                    [DatePublished] => 2014-12-07 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

GREECE AND SWITZERLAND

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1399954
                    [Title] => Selenium slows Graves’ orbitopathy progression
                    [Summary] => 
Oral selenium significantly improves patients’ quality of life and slows the progression of mild Graves’ orbitopathy, according to the findings of a year-long randomized controlled trial.

                    [DatePublished] => 2014-12-07 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Selenium slows Graves’ orbitopathy progression

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 7, 2014 - 12:00am

Oral selenium significantly improves patients’ quality of life and slows the progression of mild Graves’ orbitopathy, according to the findings of a year-long randomized controlled trial.

Opinion